These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

607 related items for PubMed ID: 19177783

  • 1. [Clinical basis of macrolides apply in diseases of the respiratory tract].
    Płusa T.
    Pol Merkur Lekarski; 2008 Nov; 25(149):432-6. PubMed ID: 19177783
    [Abstract] [Full Text] [Related]

  • 2. Macrolides and airway inflammation in children.
    Shinkai M, Rubin BK.
    Paediatr Respir Rev; 2005 Sep; 6(3):227-35. PubMed ID: 16153572
    [Abstract] [Full Text] [Related]

  • 3. [Immunomodulating effects of macrolides: areas of possible clinical use in pulmonology].
    Sinopal'nikov AI.
    Ter Arkh; 2011 Sep; 83(8):10-20. PubMed ID: 21961326
    [Abstract] [Full Text] [Related]

  • 4. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections.
    Appelbaum PC.
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544
    [Abstract] [Full Text] [Related]

  • 5. [The macrolide antibiotics in treatment of skin diseases].
    Owczarek W, Paluchowska E.
    Pol Merkur Lekarski; 2008 Nov; 25(149):429-31. PubMed ID: 19177782
    [Abstract] [Full Text] [Related]

  • 6. Immunomodulatory effects of macrolide antibiotics - part 2: advantages and disadvantages of long-term, low-dose macrolide therapy.
    Altenburg J, de Graaff CS, van der Werf TS, Boersma WG.
    Respiration; 2011 Nov; 81(1):75-87. PubMed ID: 20733282
    [Abstract] [Full Text] [Related]

  • 7. [Lower tract infections as potential indication for therapy with macrolides].
    Jahnz-Rózyk K, Targowski T.
    Pol Merkur Lekarski; 2008 Nov; 25(149):426-8. PubMed ID: 19177781
    [Abstract] [Full Text] [Related]

  • 8. The role of atypical infections and macrolide therapy in patients with asthma.
    Rollins DR, Good JT, Martin RJ.
    J Allergy Clin Immunol Pract; 2014 Nov; 2(5):511-7. PubMed ID: 25213043
    [Abstract] [Full Text] [Related]

  • 9. A proposal of clinical breakpoints for amoxicillin applicable to porcine respiratory tract pathogens.
    Schwarz S, Böttner A, Goossens L, Hafez HM, Hartmann K, Kaske M, Kehrenberg C, Kietzmann M, Klarmann D, Klein G, Krabisch P, Luhofer G, Richter A, Schulz B, Sigge C, Waldmann KH, Wallmann J, Werckenthin C.
    Vet Microbiol; 2008 Jan 01; 126(1-3):178-88. PubMed ID: 17686589
    [Abstract] [Full Text] [Related]

  • 10. Respiratory viruses and atypical bacteria triggering severe asthma exacerbation in children.
    Leung TF, Chan PK, Wong GW, Fok TF, Ng PC.
    Hong Kong Med J; 2013 Jun 01; 19 Suppl 4():11-4. PubMed ID: 23775180
    [Abstract] [Full Text] [Related]

  • 11. New macrolide, lincosaminide and streptogramin B antibiotics.
    Kirst HA.
    Expert Opin Ther Pat; 2010 Oct 01; 20(10):1343-57. PubMed ID: 20645886
    [Abstract] [Full Text] [Related]

  • 12. [Do ketolides have real advantages over macrolides?].
    Muñoz Bellido JL, García-Rodríguez JA.
    Rev Esp Quimioter; 2003 Sep 01; 16(3):273-6. PubMed ID: 14702118
    [No Abstract] [Full Text] [Related]

  • 13. Infection site concentrations: their therapeutic importance and the macrolide and macrolide-like class of antibiotics.
    Drusano GL.
    Pharmacotherapy; 2005 Dec 01; 25(12 Pt 2):150S-158S. PubMed ID: 16305286
    [Abstract] [Full Text] [Related]

  • 14. Antibiotics for the allergist: part 2.
    La Shell MS, Tankersley MS.
    Ann Allergy Asthma Immunol; 2009 Jan 01; 102(1):1-7; quiz 8-10, 40. PubMed ID: 19205278
    [Abstract] [Full Text] [Related]

  • 15. [Atypical infection of the respiratory tract and bronchial asthma].
    Jahnz-Rózyk K, Targowski T.
    Pol Merkur Lekarski; 2007 Nov 01; 23(137):325-7. PubMed ID: 18361312
    [Abstract] [Full Text] [Related]

  • 16. British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease.
    Smith D, Du Rand I, Addy CL, Collyns T, Hart SP, Mitchelmore PJ, Rahman NM, Saggu R.
    Thorax; 2020 May 01; 75(5):370-404. PubMed ID: 32303621
    [No Abstract] [Full Text] [Related]

  • 17. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.
    Cameron EJ, McSharry C, Chaudhuri R, Farrow S, Thomson NC.
    Clin Exp Allergy; 2012 Sep 01; 42(9):1302-12. PubMed ID: 22925316
    [Abstract] [Full Text] [Related]

  • 18. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators.
    Giamarellos-Bourboulis EJ.
    Int J Antimicrob Agents; 2008 Jan 01; 31(1):12-20. PubMed ID: 17935949
    [Abstract] [Full Text] [Related]

  • 19. [Macrolides in antibiotic therapy of infections of the bronchial tree].
    Płusa T.
    Pol Merkur Lekarski; 2011 Sep 01; 31(183):139-44. PubMed ID: 21991841
    [Abstract] [Full Text] [Related]

  • 20. [Management of bacterial exacerbations of obstructive lung diseases].
    Kozielski J.
    Pol Merkur Lekarski; 2011 Oct 01; 31(184):201-3. PubMed ID: 22097174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.